NO2022033I1
(no )
2022-07-22
Rimegepant or a pharmaceutically acceptable salt thereof
NO2020018I1
(no )
2020-06-17
Darolutamide, optionally in the form of a pharmaceutically acceptable salt or ester thereof
NO2020006I1
(no )
2020-03-11
upadacitinib or a pharmaceutically acceptable salt thereof
CY2019025I1
(el )
2019-11-27
Φαρμακευτικη συνθεση η οποια περιλαμβανει εναν μη νουκλεοσιδικο αναστολεα αναστροφης μεταγραφασης
NL300891I2
(nl )
2017-11-21
Lotilaner en zouten daarvan
HRP20160579T1
(hr )
2016-07-29
Spoj indola i njegova farmaceutska upotreba
DK2402317T3
(da )
2013-10-07
DGAT-inhibitor
BRPI1013639A2
(pt )
2016-04-19
medicamentos antidiabéticos
EP2403441A4
(en )
2016-08-31
STENT
IT1395925B1
(it )
2012-11-02
Poliestere biodegradabile.
BRPI1006505A2
(pt )
2018-05-29
embalagem
FR2936709B1
(fr )
2012-05-11
Comprimes alcoolo-resistants.
BRPI1016117A2
(pt )
2016-04-12
derivados de isoxazol-isoxazol e isoxasol-isotiazol.
NL301214I2
(nl )
2023-04-19
Lasmiditan en farmaceutisch aanvaardbare zouten daarvan
DK2493353T3
(da )
2024-07-15
En møbel
BR112013012313A2
(pt )
2019-09-24
combinação farmacêutica de paclitaxel e um inibidor de cdk
UY33111A
(es )
2011-07-29
Jeringas
HUE043524T2
(hu )
2019-08-28
DGATl inhibitort tartalmazó gyógyászati készítmény
BR112012002334A2
(pt )
2016-05-31
sensor com orifício para transcontactação
BRPI1008714A2
(pt )
2016-03-08
dispensador.
DK2437736T3
(da )
2017-11-13
Lægemiddelindgivelsessystemer
DK2403764T3
(da )
2014-06-23
Opbevaringsæske
EP2407183A4
(en )
2014-03-12
DEVELOPABLE STENT
BRPI1014821A2
(pt )
2016-04-05
"inibidores de replicação de hiv"
FI20096189L
(fi )
2011-05-18
Vuoteen turvakaide